Letter by Lavine Regarding Article, "Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation"

Circulation. 2015 Oct 6;132(14):e179. doi: 10.1161/CIRCULATIONAHA.114.014405.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / therapeutic use*
  • Hemorrhage / chemically induced*
  • Humans
  • Medicare / statistics & numerical data*
  • Warfarin / therapeutic use*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Warfarin